Therapeutic Decision-Making in the Adjuvant Setting in HR+ Breast Cancer - Episode 3
May 20, 2021
Kevin Kalinsky, MD, MS, of Emory Winship Cancer Institute, discusses treatment options for HR-positive/HER2-negative breast cancer and comments on the evolving role of genomic testing in regard to treatment selection.
"breast" - Google News
May 20, 2021 at 08:07PM
https://ift.tt/3hElRN3
EP. 3: Informed Decision-Making in HR+ Breast Cancer - Cancer Network
"breast" - Google News
https://ift.tt/2ImtPYC
https://ift.tt/2Wle22m
Bagikan Berita Ini
0 Response to "EP. 3: Informed Decision-Making in HR+ Breast Cancer - Cancer Network"
Post a Comment